{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T20:41:23Z","timestamp":1781037683411,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.chest.2025.11.042","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T02:54:13Z","timestamp":1765421653000},"page":"1115-1123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of and Outcomes Related to Intrapleural Enzyme Therapy for Complicated Parapneumonic Effusion and Empyema in an Integrated Health System"],"prefix":"10.1016","volume":"169","author":[{"given":"Eduardo","family":"Solbes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khanh K.","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Kipnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori C.","family":"Sakoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Velotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent X.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2872-3388","authenticated-orcid":false,"given":"Laura C.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.chest.2025.11.042_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.athoracsur.2018.02.027","article-title":"Current state of empyema management","volume":"105","author":"Semenkovich","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.chest.2025.11.042_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa1012740","article-title":"Intrapleural use of tissue plasminogen activator and DNase in pleural infection","volume":"365","author":"Rahman","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2025.11.042_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1513\/pats.200510-113JH","article-title":"Parapneumonic effusions and empyema","volume":"3","author":"Light","year":"2006","journal-title":"Proc Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.chest.2025.11.042_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jtcvs.2006.09.038","article-title":"Management of pleural space infections: a population-based analysis","volume":"133","author":"Farjah","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.chest.2025.11.042_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.hrtlng.2021.02.015","article-title":"The incidence of pleural effusion in COVID-19 pneumonia: state-of-the-art review","volume":"50","author":"Chong","year":"2021","journal-title":"Heart Lung"},{"issue":"1","key":"10.1016\/j.chest.2025.11.042_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s13104-020-05210-2","article-title":"Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study","volume":"13","author":"Jiang","year":"2020","journal-title":"BMC Res Notes"},{"issue":"9","key":"10.1016\/j.chest.2025.11.042_bib7","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1513\/AnnalsATS.201602-127OC","article-title":"Concurrent intrapleural instillation of tissue plasminogen activator and DNase for pleural infection. A single-center experience","volume":"13","author":"Majid","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.chest.2025.11.042_bib8","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.chest.2022.06.008","article-title":"Bleeding risk with combination intrapleural fibrinolytic and enzyme therapy in pleural infection: an international, multicenter, retrospective cohort study","volume":"162","author":"Akulian","year":"2022","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2025.11.042_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7812\/TPP\/22.172","article-title":"Comparing Kaiser Permanente members to the general population: implications for generalizability of research","volume":"27","author":"Davis","year":"2023","journal-title":"Perm J"},{"issue":"5","key":"10.1016\/j.chest.2025.11.042_bib10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MLR.0b013e3182881c8e","article-title":"Risk-adjusting hospital mortality using a comprehensive electronic record in an integrated health care delivery system","volume":"51","author":"Escobar","year":"2013","journal-title":"Med Care"},{"key":"10.1016\/j.chest.2025.11.042_bib11","series-title":"Generalized Linear Mixed Models: Modern Concepts, Methods and Applications","author":"Stroup","year":"2012"},{"issue":"1","key":"10.1016\/j.chest.2025.11.042_bib12","doi-asserted-by":"crossref","first-page":"00590","DOI":"10.1183\/23120541.00590-2021","article-title":"An international survey on the use of intrapleural tissue plasminogen activator\/DNase therapy for pleural infection","volume":"8","author":"Lau","year":"2022","journal-title":"ERJ Open Res"},{"issue":"3","key":"10.1016\/j.chest.2025.11.042_bib13","first-page":"520","article-title":"Etiology and management of spontaneous haemothorax","volume":"7","author":"Patrini","year":"2015","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.chest.2025.11.042_bib14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1513\/AnnalsATS.201608-594BC","article-title":"Safety and efficacy of tissue plasminogen activator and DNase for complicated pleural effusions secondary to abdominal pathology","volume":"14","author":"Majid","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"9","key":"10.1016\/j.chest.2025.11.042_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMoa042473","article-title":"U.K. Controlled trial of intrapleural streptokinase for pleural infection","volume":"352","author":"Maskell","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.chest.2025.11.042_bib16","article-title":"Extended dwell time improves results of fibrinolytic therapy for complex pleural effusions","volume":"12","author":"Patino","year":"2020","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.chest.2025.11.042_bib17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1513\/AnnalsATS.201609-673OC","article-title":"Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project","volume":"14","author":"Popowicz","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"12","key":"10.1016\/j.chest.2025.11.042_bib19","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1164\/rccm.202305-0854OC","article-title":"Early video-assisted thoracoscopic surgery or intrapleural enzyme therapy in pleural infection: a feasibility randomized controlled trial. The Third Multicenter Intrapleural Sepsis Trial-MIST-3","volume":"208","author":"Bedawi","year":"2023","journal-title":"Am J Respir Crit Care Med"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369225058258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369225058258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T09:41:01Z","timestamp":1775641261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369225058258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0012369225058258"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2025.11.042","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of and Outcomes Related to Intrapleural Enzyme Therapy for Complicated Parapneumonic Effusion and Empyema in an Integrated Health System","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2025.11.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}